TWI663994B - Medicine volatilization bag and medicine volatilization container containing the same - Google Patents

Abstract

An object of the present invention is to improve the elasticity of selection when a volatile agent such as a fragrance or a deodorant is used.

The present invention includes a soft inner bag body 12 formed of a non-gas-permeable film 14 and encapsulating a volatile agent 15 therein, and a soft outer bag body 13 that houses the inner bag body 12, and the inner bag body 12 can be subjected to external force. The internal pressure rises and is unsealed. The outer bag body 13 has one side and the opposite side, and at least one side of the outer bag body 13 is composed of a microporous sheet 17 having a plurality of micropores for infiltration of the volatile agent 15.

Description

Medicine volatilization bag and medicine volatilization container containing the same

The present invention relates to a medicament volatilization bag volatilely containing a volatile medicament such as a fragrance or a deodorant, and a medicament volatilization container containing the same.

Conventionally, as a person for spreading a fragrance or a deodorant in a room or the like, there is, for example, one disclosed in Patent Document 1.

The inner surface of the fragrance packaging system disclosed in Patent Document 1 is heat-sealable, and includes a multilayer film having a gas-barrier film layer. The open end is sealed with a strong peeling strength until the contents are pressed firmly. The inner packaging bag is filled with a sealed volatile fragrance to the extent that the bag can be easily unsealed, and the inner packaging bag sealed with the fragrance is filled with a gas-permeable film and the outer packaging bag is sealed. (Refer to FIG. 2 of Patent Document 1).

When using the fragrance packaging body, the internal packaging bag is pressed from the outside through the external packaging bag, and the internal pressure caused by the external force rises, so that the sealing portion of the internal packaging bag is unsealed, and the fragrance flows out to Inside the outer packaging bag. Since the outer packaging bag is formed of a gas-permeable film, the fragrance flowing out into the outer packaging bag is volatilized to the outside through the gas-permeable film.

[Prior technical literature] [Patent Literature]

[Patent Document 1] Japanese Public Sho 60-1730

However, in the fragrance packaging body disclosed in the above-mentioned Patent Document 1, the fragrance is volatilized toward the outside of the outer packaging bag, and therefore both sides of the outer packaging bag are formed of a gas-permeable film. However, depending on the type of fragrance, it is difficult to volatilize the fragrance from the outer packaging bag. Specifically, prior gas-permeable films such as polyethylene have poor permeability to alcohols such as linalool or dihydrogeraniol, which are the main components of fragrances constituting fragrances, and restrict volatilization.

That is, the fragrance used in the fragrance has various components and also involves various chemical properties. In addition, the gas-permeable film constituting the outer packaging bag also has different gas permeability depending on the material. Therefore, in order to improve the adherence of the fragrance and the gas-permeable film, it is necessary to select a combination of the fragrance and the gas-permeable film that allows the fragrance to be well volatilized from the outer packaging bag. Therefore, there is a problem that the so-called fragrance that can be used for the gas-permeable film constituting the outer packaging bag is limited.

Therefore, the present invention has been proposed in view of the above-mentioned problems, and an object thereof is to provide a medicament volatilization bag and a medicament volatilization container which can improve the flexibility of selection when using a volatile medicament such as a fragrance or a deodorant.

As a technical means to achieve the above purpose, the pharmaceutical volatilization bag of the present invention includes: a soft inner bag body formed of a non-gas-permeable film, and the volatile medicine is sealed inside; and a soft outer bag body, which contains The inner bag body; the inner bag system is constituted in such a way that the internal pressure can be increased by external force to be unsealed. The outer bag body has one side and the other side opposite to it, and at least one side is provided with a majority of the volatile drug infiltration. Porous microporous sheet.

Here, the microporous sheet constituting at least one side of the outer bag body is different from a gas-permeable film that permeates a gas of a volatile agent at a molecular level, but is a degree for the volatile agent to infiltrate and leak out to the surface of the sheet Physically formed with a plurality of micropores. In addition, the other surface of the outer bag body may be constituted by, for example, a sheet that cannot be infiltrated by a volatile drug, in addition to the above-mentioned microporous sheet structure. As the sheet that the volatile agent does not wet, a gas-permeable film that allows the gas of the volatile agent to pass through at the molecular level, or a non-gas-permeable film that blocks the gas of the volatile agent can be used. In this way, the material of the sheet constituting the other side of the outer bag body is arbitrary.

In the pharmaceutical volatile bag of the present invention, if the inner bag body is unsealed due to an increase in internal pressure caused by an external force, the volatile medicine enclosed in the inner bag body will flow out into the outer bag body. At least one side of the outer bag system is composed of a microporous sheet having a plurality of micropores that can be infiltrated by the volatile agent, so the volatile agent flowing out of the outer bag body is infiltrated with the micropores of the microporous sheet and exuded to the sheet Surface and volatilize to the outside.

In this way, the microporous sheet constituting at least one side of the outer bag body is physically formed with a plurality of micropores to the extent that the volatile agent infiltrates and oozes out to the surface of the sheet, so it is different from the previous gas permeable film and it is not necessary to select In combination with volatile agents involving a variety of chemical properties, a variety of volatile agents can be used to make the volatile agents easily volatilize from the outer bag body. In this way, for the microporous sheet constituting at least one side of the outer bag body, since the usable volatile agent is not limited, the selection flexibility can be improved when the volatile agent is used.

Because the microporous sheet uses a plurality of micropores for the volatile agent to infiltrate and ooze out to the surface of the sheet, compared with the gas-permeable sheet, the volatility of the volatile agent also increases, and the volatile agent can be taken from the outer bag. The body evaporates well. Therefore, it is not necessary to form both sides of the outer bag body with a microporous sheet, and it is sufficient to form at least one side of the outer bag body with a microporous sheet.

In addition, the pharmaceutical volatilization container of the present invention is characterized in that it includes a pharmaceutical volatilization bag and a casing. The casing contains the pharmaceutical volatilization bag, and a portion corresponding to the inner bag body is provided with an external force imparting external force to the inner bag body through the outer bag body. Pressing section. In this medicine volatilizing container, it is preferable that the medicine volatilizing bag is arranged in a state in which one side of the outer bag body made of a microporous sheet faces the upper side, and the outer The case is mounted on the member to be mounted.

When using the medicament volatilization container of the present invention, the medicament volatilization bag stored in the housing is pressed into the pressing portion of the housing, thereby applying an external force to the inner bag body through the outer side of the medicament volatilization bag. The internal pressure of the inner bag body is increased by applying the external force, and the inner bag body is unsealed with the increase of the inner pressure. By the unsealing of the inner bag body, the volatile medicine enclosed in the inner bag body flows out into the outer bag body. The volatile medicine flowing out of the outer bag body is infiltrated with the micropores of the microporous sheet and exuded to the surface of the sheet, thereby volatilizing to the outside.

As the use form of the medicine volatilization container, a case where the medicine volatilization bag is arranged in a vertical state in the case, and a case where the medicine volatilization bag is arranged in a horizontal state in the case may be adopted. In particular, in the use form of the medicament volatilization container in which the medicament volatilization bag is arranged in the casing in a horizontal state, as described above, the volatilization of the medicament may be arranged only when one side of the outer bag body formed of a microporous sheet faces the upper side. The bag can suppress the volatile pharmaceuticals that are infiltrated from the microporous sheets and leaked out to the surface of the sheet into droplets and dripping to the inside or outside of the case.

According to the present invention, at least one side of the outer bag system is composed of a microporous sheet having a plurality of micropores that can be infiltrated by a volatile agent, so the microporous sheet is different from the previous gas permeable film, and it is not necessary to select and involve multiple chemistry The combination of volatile agents can use a variety of volatile agents, so the volatile agents can be easily volatilized from the outer bag body. In this way, for the microporous sheet constituting at least one side of the outer bag body, since the usable volatile agent is not limited, the selection flexibility can be improved when the volatile agent is used. As a result, a medicament volatilization bag and a medicament volatilization container that can be easily and quickly coped with for various applications can be realized.

11‧‧‧Pharmaceutical evaporation bag

12‧‧‧ inside pocket

13‧‧‧outer bag body

14‧‧‧Non-gas permeable film

15‧‧‧volatile agent

16‧‧‧Edge

17‧‧‧ microporous sheet

18‧‧‧ Non-wettable sheet

19‧‧‧ Side

21‧‧‧Shell

22‧‧‧Pharmaceutical volatile container

23‧‧‧shell half

24‧‧‧ shell half

25‧‧‧pin

26‧‧‧ recess

27‧‧‧Claw

28‧‧‧ Claw

29‧‧‧Pressing section

30‧‧‧Connection Department

31‧‧‧ opening

32‧‧‧ volatile hole

33‧‧‧Four Corners

34‧‧‧ Press into the wall sheet

35‧‧‧ Supports wall sheet

36‧‧‧Position limit wall

37‧‧‧ Receiving Department

38‧‧‧ support

39‧‧‧Inner round wall

40‧‧‧outer circular wall panel

41‧‧‧Cross wall panel

42‧‧‧ Adhesive tape

43‧‧‧Trash Can

44‧‧‧ Installed component (dustbin cover)

45‧‧‧Pressing surface

FIG. 1 is an exploded perspective view showing an assembly of a medicine volatilizing bag according to an embodiment of the present invention.

FIG. 2 is a perspective view showing the assembly of the volatile medicine bag of FIG. 1.

Fig. 3 is a sectional view taken along line A-A in Fig. 2.

FIG. 4 is a cross-sectional view showing a use state of the volatile medicine bag of FIG. 3.

Fig. 5 is a view showing a case for storing a medicine volatile bag, (A) is an upper surface view, (B) is a front view, and (C) is a lower surface view.

Fig. 6 is a sectional view taken along line B-B of Fig. 5 (A).

Fig. 7 is a view showing the lower surface of the shell half on one side.

Fig. 8 is a sectional view taken along the line C-C in Fig. 7.

Fig. 9 is a top view of the casing half on the other side.

Fig. 10 is a sectional view taken along line D-D in Fig. 9.

FIG. 11 is an exploded perspective view showing the assembly of a pharmaceutical volatilization container including a casing and a pharmaceutical volatilization bag.

FIG. 12 is an exploded perspective view showing a state in which a volatile medicine bag is placed on the casing. FIG.

FIG. 13 is a perspective view showing the assembly of a pharmaceutical volatilization container including a casing and a pharmaceutical volatilization bag.

FIG. 14 is a cross-sectional view of a use state in which a volatile medicine container is installed on a lid of a garbage bin.

FIG. 15 is an enlarged sectional view of a main part of FIG. 14.

FIG. 16 is a cross-sectional view for explaining the essentials of the inner bag body of the unsealed pharmaceutical evaporating bag.

FIG. 17 is an enlarged sectional view of a main part showing a state after unsealing the inner bag body of the pharmaceutical evaporating bag shown in FIG. 15.

Hereinafter, embodiments of the medicament volatilization bag and the medicament volatilization container containing the same are described in detail. In the following embodiment, it is exemplified that the fragrance is used as a waste container and is installed inside the cover of the waste container. However, in addition to the fragrance of the waste container, it can also be used as a fragrance or deodorant in a room or a car. Apply it.

1 to 4 show an example of a volatile medicine bag 11, FIG. 1 is an exploded perspective view of the assembly, and FIG. 2 is a group The assembled perspective view, FIG. 3 is a cross-sectional view taken along line A-A in FIG. 2, and FIG. 4 is a cross-sectional view in use. As shown in FIG. 1 to FIG. 3, the medicine volatilization bag 11 has a dual structure including a soft inner bag body 12 and a soft outer bag body 13 that houses the inner bag body 12. In addition, in FIG. 3 and FIG. 4, the thickness and the internal space of the inner bag body 12 and the outer bag body 13 are exaggeratedly shown.

The rectangular inner bag body 12 is formed into a bag shape with a transparent non-gas-permeable film 14 in plan view, and a volatile drug 15 is sealed inside. The non-gas-permeable film 14 as a material of the inner bag body 12 includes a thermoplastic synthetic resin including, for example, polyester, polyamide, saponified ethylene-vinyl acetate copolymer, modified polyvinyl alcohol, polyvinylidene chloride, and the like. Or multilayer laminated material of one or more metal foils such as aluminum. In addition, as the volatile medicine 15, a medicine containing a volatile perfume is used. For example, alkane-based hydrocarbons, glycol ethers, glycols, ethanols, esters, ketones, lactones, and aldehydes can be used. The volatile agent is not limited to a liquid, and may be a solid, a gel, a sol, or a mixture thereof. When the volatile medicine 15 is colored in advance, the inner bag body 12 is formed by the transparent film 14, so that the volatile medicine 15 is easily visually confirmed from the outside. Moreover, the volatile drug 15 may be made tacky by a thickener. Examples of the thickener include glycerin, sugar fatty acid esters, waxes, thickening polysaccharides, carrageenan, minerals, metal soaps, long-chain fatty acids, polyvalent metal salts of long-chain fatty acids, amino acid derivatives, and sugar derivatives. Wait.

The inner bag body 12 is formed by folding a piece of non-gas-permeable film 14 in half, and heat-welding the three sides 16 of the openings to form a bag shape. The three side portions 16 are sealed with a strength that can be unsealed by increasing the internal pressure by an external force. In this case, the number and location of the side portions 16 sealed in a detachable manner are arbitrary. In addition, the inner bag body 12 is formed by folding one non-gas-permeable film 14 in half and sealing the three sides 16 in a detachable manner. However, it can also be provided by overlapping two non-gas-permeable films 14. It is bag-shaped. In this case, the number and location of the side portions 16 sealed in a detachable manner are also arbitrary.

In addition, the rectangular outer bag body 13 in plan view is formed by superposing a microporous sheet 17 constituting one surface on one side and a transparent sheet 18 constituting one surface on the other side facing it, and applying heat The four sides 19 of the opening are sealed and heat-sealed to form a bag shape. The microporous sheet 17 may constitute a part of one surface in addition to the entire surface of one surface of the outer bag body 13. The four side portions 19 of the outer bag body 13 are different from the case of the inner bag body 12 and are sealed in such a way that they cannot be unsealed due to an increase in internal pressure caused by an external force. By forming the other surface side of the outer bag body 13 with a transparent sheet 18, it is easy to visually confirm the inner bag body 12 and the volatile medicine 15 from the other side. In this embodiment, the case where the other side of the outer bag body 13 is formed by the transparent sheet 18 will be described, but the sheet constituting the other side of the outer bag body 13 does not necessarily need to be transparent, and may be non-transparent or translucent. It may also be a microporous sheet.

The microporous sheet 17 constituting one surface of the outer bag body 13 has a plurality of micropores capable of infiltrating the volatile medicine 15. That is, unlike the gas-permeable film that allows the gas of the volatile agent 15 to permeate, a plurality of micropores are physically formed to the extent that the volatile agent 15 infiltrates and oozes out to the surface of the sheet. Examples of the microporous sheet 17 include various polyethylenes such as high density polyethylene, medium density polyethylene, low density polyethylene, linear low density polyethylene, ultra high molecular weight polyethylene, or ethylene-vinyl acetate Copolymers and saponifications thereof, ethylene-acrylic copolymers, ethylene-propylene copolymers, various olefin resins and copolymers thereof, diene resins and copolymers thereof, polyethylene terephthalate, polyparaphenylene Butyl diformate, polycarbonate, polystyrene, polyvinyl chloride, polyvinylidene chloride, polycarbonate, polyurethane, various acrylic resins, polyvinyl alcohol, polyimide, fluororesin, silicone resin, ring Semi-synthetic resins such as oxyresin and Saifan. The resin used for the microporous sheet 17 may be used alone or as a copolymer, a mixture, or the like. Furthermore, a multilayer sheet formed by using a plurality of the above-mentioned resins to form a plurality of layers may be used. In order to form a multilayer sheet, it is carried out by a known method such as dry lamination, coextrusion, and extrusion lamination. It is also possible to knead various additives during molding into a sheet, and then perform stretching or heat treatment after molding. Coating, vapor deposition, etc. may be performed after molding. When the sheet is two or more layers, one of the layers may be a metal foil, a metal vapor-deposited film, or an inorganic vapor-deposited film layer.

The transparent sheet 18 constituting the other side of the outer bag body 13 cannot penetrate the volatile medicine 15 of the slices. That is, unlike the microporous sheet 17 described above, the volatile drug 15 is not wetted. The transparent sheet 18 that has not been impregnated with the volatile agent 15 may be any of a gas-permeable film that allows the gas of the volatile agent 15 to pass through at a molecular level, or a non-gas-permeable film that blocks the gas of the volatile agent 15 . As the non-gas-permeable film, any material that can be selected from the materials used in the inner bag body 12 may be used. Examples of the gas-permeable film include thermoplastic resins such as polyethylene, polypropylene, ethylene-vinyl acetate copolymer resins, ionic polymer resins, ethylene-acrylic copolymer resins, and ethylene-α-olefin copolymer resins. Multi-layer laminated materials.

In the pharmaceutical evaporating bag 11 including the structure described above, as shown in FIG. 4, if the internal pressure of the inner bag body 12 is increased by the action of an external force (refer to the white arrow in the figure), the three sealed sides 16 After the inner bag body 12 is unsealed, the volatile medicine 15 enclosed in the inner bag body 12 flows out into the outer bag body 13. The outer bag body 13 is composed of a microporous sheet 17 having a plurality of micropores capable of infiltrating the volatile agent 15 on one side (upper surface in the figure), so the volatile agent 15 flowing out into the outer bag body 13 is infiltrated. The micropores in the microporous sheet 17 are exuded to the surface of the sheet, thereby volatilizing to the outside (see the dotted arrow in the figure).

In this way, the microporous sheet 17 constituting one surface of the outer bag body 13 is physically formed with a plurality of micropores to the extent that the volatile agent 15 is infiltrated to the surface of the sheet, so it is different from the previous gas permeable film. It is not necessary to select a combination with the volatile agent 15 involving a variety of chemical properties, and a plurality of volatile agents 15 can be used to make the volatile agent 15 easily volatilize from the outer bag body 13. In this way, the microporous sheet 17 constituting one surface of the outer bag body 13 is not limited to the volatile agent 15 that can be used. Therefore, when the volatile agent 15 is used, the selection flexibility can be improved.

The microporous sheet 17 is exuded to the surface of the sheet by infiltrating the volatile agent 15 with a plurality of micropores. Therefore, compared with the gas-permeable sheet, the volatile amount of the volatile agent 15 also increases, and the volatile agent 15 can be increased. Volatilization is good from the outer bag body 13. Therefore, it is not necessary to form both sides of the outer bag body 13 with the microporous sheet 15, and only the outer side with the microporous sheet One side of the bag body 13 is sufficient. As a result, the other surface of the outer bag body 13 may be constituted by a sheet such as a gas-permeable film or a non-gas-permeable film that the volatile agent 15 cannot penetrate.

In the case where the above-mentioned medicament volatilization bag 11 is used as a fragrance in a trash can, the medicament volatilization bag 11 is stored in a medicament volatilization container of a resin case 21 made of plastic or the like and used. Figures 5 to 10 illustrate the housing 21, and Figure 5 illustrates the housing 21 having a two-part split structure in which two housing halves 23, 24 are butted, (A) is a top view, (B) is a front view, and (C) is Bottom view, FIG. 6 is a cross-sectional view taken along the line BB of FIG. 5 (A), FIG. 7 is a bottom view of the housing half 23 (hereinafter referred to as the upper casing) on one side, and FIG. 8 is taken along the CC line of FIG. Sectional view, FIG. 9 is a top view of the casing half body 24 (hereinafter referred to as a lower casing) on the other side, and FIG. 10 is a sectional view taken along line DD of FIG. 9.

As shown in FIGS. 5 (A) to (C) and FIG. 6, the casing 21 adopts a two-part structure in which two circular dish-shaped upper and lower casings 23 and 24 are butted. The casing 21 is provided in the form of a replaceable used medicine volatilization bag 11 and is provided on the outer periphery of each of the upper casing 23 shown in FIGS. 7 and 8 and the lower casing 24 shown in FIGS. 9 and 10. It is structured as follows. The structure in which the pin 25 of the upper case 23 is inserted into the recessed hole 26 of the lower case 24 allows the upper and lower cases 23 and 24 to be aligned, and the structure of the claw 27 of the upper case 23 and the claw 28 of the lower case 24 is locked by hooking, The upper and lower cases 23 and 24 have a fitting structure that can be separated by one touch. The casing 21 adopts a fitting structure that can be separated by hooking and locking of the claws 27 and 28, but it can also be opened and closed by a hinge structure, so that the used medicine volatile bag 11 can be replaced.

In the upper case 23, a circular pressing portion 29 for applying an external force to the inner bag body 12 of the medicine volatilizing bag 11 through the outer bag body 13 is provided at a central portion thereof. The pressing portion 29 is integrally formed in a state where the upper casing 23 is supported on one side via a flexible connecting portion 30, and is disposed in the opening portion 31 of the upper casing 23 and can be pressed in. Around the circumferential direction of the pressing portion 29, a plurality of volatilization holes 32 are formed for releasing the medicinal gas of the volatile medicine 15. The upper case 23 is formed integrally with a portion corresponding to the four corner portions 33 of the outer bag body 13. There are four press-fitting wall pieces 34. When these press-fitting wall pieces 34 are docked with the upper and lower shells 23 and 24, the corner portions 33 of the bag body 13 positioned on the outer side of the medicine volatilizing bag 11 of the lower shell 24 (refer to FIG. Fig. 9) Press in the lower case 24.

Four supporting wall pieces 35 are formed integrally and vertically on the lower casing 24 for the outer bag body 13 on which the medicine volatilization bag 11 is placed. In addition, four position-regulating wall pieces 36 for restricting the position of the outer bag body 13 by abutting on the side portions 19 of the outer bag body 13 are integrally provided. The front end portion of the position-restricting wall piece 36 is hook-shaped, and the outer bag body 13 is pressed into the front end portion of the position-restricting wall piece 36 to prevent the outer bag body 13 from floating, thereby stabilizing the position restriction. A receiving portion 37 is integrally provided at a central portion of the lower case 24. The receiving portion 37 supports the inner bag body 12 of the medicine volatilization bag 11 that is provided with an external force by the pressing portion 29 through the outer bag body 13. The receiving portion 37 has a supporting surface 38 which is inclined so as to face the pressing portion 29 which is pushed in through the medicine volatilizing bag 11. The receiving part 37 forms a double structure of the inner circular wall sheet 39 and the outer circular wall sheet 40, and its supporting surface 38 is the inner circular wall sheet 39 and the cross-shaped wall sheet 41 and the outer circular wall sheet on the inner side thereof. 40 upper end.

In addition, an adhesive tape 42 is provided at a central portion on the outer side of the lower case 24 for attaching the medicine volatilizing container 22 to the inside of the lid of the dustbin. The lower case 24 is not provided with a volatile hole 32. Since the lower case 24 is provided with an adhesive tape 42 for mounting the medicine volatilization container 22 on the inner side of the lid of the garbage bin, no volatility holes 32 are provided in the lower case 24, which can prevent the volatility of the volatilization from the medicine volatilization bag 11 during use. The medicament 15 reduces the adhesive force of the adhesive tape 42 disposed close to the lower case 24 or damages the material of the lid of the trash can.

With reference to FIGS. 11 to 13, the method of filling the above-mentioned medicinal volatilization bag 11 to the above-mentioned outer shell 21 will be described in detail below. FIGS. 11 to 13 are examples illustrating the pharmaceutical volatilization container 22 in which the pharmaceutical volatilization bag 11 is put into the above-mentioned casing 21, and FIGS. 11 and 12 are exploded perspective views of assembly, and FIG. 13 is a perspective view of assembly end.

On the supporting wall sheet 35 of the lower case 24, a rectangular medicine evaporation bag 11 is placed so that the microporous sheet 17 of the bag body 13 on the outer side of the medicine evaporation bag 11 faces the lower case 24 side, and Each side portion 19 of the medicine volatilizing bag 11 is brought into abutment with the position regulating wall piece 36 from the side, thereby positioning the medicine volatilizing bag 11. The lower case 24 on which the medicine volatilization bag 11 is placed is positioned, and the upper case is positioned with a structure including a pin 25 of the upper case 23 and a recessed hole 26 of the lower case 24, and the claws 27 of the upper case 23 and the claws of the lower case 24 The structure of 28 hooks is fitted. In this way, the assembly of the volatile medicine bag 11 to the casing 21 is completed.

When the upper and lower shells 23 and 24 are docked, the four corners 33 of the bag body 13 positioned on the outer side of the medicinal volatilization bag 11 placed on the lower shell 24 are located on or near the outer periphery of the upper and lower shells 23 and 24 (see FIG. 9). Therefore, there is a possibility of biting into or protruding from the outer peripheral portion of the upper and lower shells 23 and 24. Therefore, by press-fitting the wall piece 34 provided on the upper case 23, when the upper and lower cases 23 and 24 are docked, the four corners 33 of the outer bag body 13 of the medicine volatilizing bag 11 are pressed into the inside of the lower case 24. Thereby, the corners 33 of the outer bag body 13 on the outer side of the medicine volatilization bag 11 are prevented from biting into or between the outer peripheral portions of the upper and lower shells 23 and 24, or protruding from the outer peripheral portion, and the biting or protruding is prevented from causing the outer bag 13 ruptures and the volatile agent 15 leaks to the outside.

In the case where the above-mentioned medicinal volatilization container 22 is used as the fragrance of the garbage bin, as shown in FIG. 14 and FIG. 15, the medicinal volatilization container 22 is adhered to the member to be mounted using the adhesive tape 42 provided on the lower case 24. That is, the inside of the cover 44 of the dustbin 43. That is, the medicine volatilizing container 22 is mounted in a state where the upper case 23 faces downward and the lower case 24 faces upward, upward, and downward. In this mounted state, the medicine volatilization container 22 is maintained in a substantially horizontal state, and the medicine volatilization bag 11 stored in the medicine volatilization container 22 is held with the microporous sheet 17 facing upward. On the other hand, before or after the medicine volatilizing container 22 is mounted on the lid 44 of the trash box 43, the inner bag body 12 of the medicine volatilizing bag 11 is unsealed by the following operation.

First, by pressing the pressing portion 29 provided on the outer case 23 above the medicine volatilizing container 22 toward the inside of the container, an external force is applied to the inner bag 12 via the outer bag body 13 through the medicine volatilizing bag 11. The internal pressure of the inner bag body 12 is increased by the application of the external force, and the inner bag body 12 is unsealed when the inner pressure is increased. Since the three side portions 16 of the inner bag body 12 are sealed with a strength that can be unsealable by an increase in internal pressure caused by an external force, the unsealing of the inner bag body 12 is performed by the three side portions 16 Partially or fully open.

When an external force is applied by the pressing portion 29, as shown in FIG. 16, the pressing portion 29 provided on the upper case 23 via the connecting portion 30 is flexible because the connecting portion 30 is flexible. Press into the container. By the pressing operation of the pressing portion 29, the medicine volatilizing bag 11 is sandwiched between the receiving portion 37 and the pressing portion 29 of the lower case 24. With respect to the pressing portion 29 which is inclined by the pressing operation, the supporting surface 38 including the receiving portion 37 of the inner circular wall plate 39 and the cross-shaped wall plate 41 and the outer circular wall plate 40 is used to intervene the volatile medicine bag. 11 is inclined in the opposite way, so the pressing surface 45 of the pressing portion 29 is parallel to the supporting surface 38 of the receiving portion 37, and therefore, the entire surface of the pressing portion 29 is in contact with the medicine volatilization bag 11.

In this way, since the contact area between the pressing portion 29 and the medicament volatilizing bag 11 can be ensured to the maximum extent, a sufficient external force can be applied by the pressing portion 29 to reliably unseal the inner bag body 12 of the medicament volatilizing bag 11. In addition, the inner bag body 12 can be detached with a simple structure that includes a pressing portion 29 of the upper case 23 and a receiving portion 37 of the lower case 24 and is provided on the outer case 21 located outside the medicine evaporation bag 11.

By unsealing the inner bag body 12, as shown in FIG. 17, the volatile medicine 15 enclosed in the inner bag body 12 flows out into the outer bag body 13. The outer bag body 13 is formed by a microporous sheet 17 having a plurality of micropores capable of infiltrating the volatile medicine 15, and the upper side surface is formed. Therefore, the volatile medicine 15 flowing into the outer bag body 13 is a microporous plate The 17 micropores infiltrated and exuded to the surface of the sheet, thereby volatilizing to the outside. The volatile medicine 15 that is volatilized to the outside of the outer bag body 13 is discharged to the outside of the container through the volatile hole 32 and the opening 31 provided on the housing 23 above the medicine volatilization container 22. As described above, the volatile medicine 15 that is volatilized to the outside of the container fills the inside of the trash box 43, so that the medicine volatilization container 22 functions as the fragrance of the trash box 43.

In addition, if the volatile medicine 15 enclosed in the inner bag body 12 of the medicine volatilization bag 11 is colored in advance, the transparent sheet 18 is used to form a surface facing the upper case 23 side of the outer bag body 13, so it can be volatilized from the upper case 23 The volatile medicine flowing out of the hole 32 and the opening 31 to the outer bag 13 visually Agent 15, so it is easy to confirm the remaining amount of the volatile agent 15. As a result, when the medicine volatilizing container 22 is discarded, the discard time of the medicine volatilizing container 22 can be quickly and easily identified. In addition, when the medicine volatilizing container 22 can be replaced, the replacement time of the medicine volatilizing bag 11 can be identified quickly and easily.

In addition, since the volatile medicine bag 11 is composed of a soft inner bag body 12 and an outer bag body 13, even if the volatile medicine 15 is reduced due to the volatilization of the volatile medicine 15, the volatile medicine 15 can be reduced. The internal pressure is reduced, and the microporous sheet 17 of the outer bag body 13 is in close contact with the volatile medicine 15. In this way, an air layer cannot be formed between the microporous sheet 17 and the volatile agent 15, so the microporous sheet 17 and the volatile agent 15 are always in contact with each other. Therefore, the volatile agent 15 is depleted. It is infiltrated into the microporous sheet 17 and penetrates out of the sheet surface, so that the volatile medicine 15 can be prevented from remaining in the medicine volatile bag 11 without being reduced.

In the use form of the medicine volatilizing container 22 described above, as the fragrance of the trash box 43, the state in which the medicine volatilizing bag 11 is held inside the lid 44 of the trash box 43 in a horizontal state, that is, a so-called horizontal state is adopted. As described above, in the use form of the medicine volatilizing container 22 in which the medicine volatilizing bag 11 is arranged in the casing 21 in a horizontal state, as described above, one of the outer bag bodies 13 constituted by the microporous sheet 17 faces By disposing the medicine volatile bag 11 on the upper side, the volatile medicine 15 infiltrated by the plurality of micropores of the microporous sheet 17 and permeated on the surface of the sheet can be prevented from dripping from the inside or outside the case.

In addition, in the above embodiment, the use form of the medicine volatilization container 22 in which the medicine volatilization bag 11 is arranged in a horizontal state in the casing 21 is described, but the present invention is not limited to this, and the medicine volatilization bag may also be used. 11 The use form of a pharmaceutical volatilization container arranged in the casing in a vertical state. In this case, even if the volatile agent 15 infiltrated by the plurality of micropores of the microporous sheet 17 and permeated on the surface of the sheet becomes droplets, the droplets can be received by the casing to suppress dripping from the outside of the casing. .

The present invention is not limited to the embodiments described above, without departing from the gist of the present invention. Within the scope, of course, it can be further implemented in various forms. The scope of the present invention is as shown in the scope of the patent application, and further includes all the equivalent meanings and changes in the scope described in the scope of the patent application.

Claims (4)

A medicament volatilization bag, comprising: a soft inner bag body formed of a non-gas-permeable film and a liquid volatile medicine sealed therein; and a soft outer bag body containing the above-mentioned inner bag body; The inner bag system is constructed in such a way that it can be unsealed by an increase in internal pressure caused by an external force; the outer bag body has one side and the other side opposite to it, at least the one side of which is infiltrated by the volatile agent and has a plurality of Microporous microporous sheet. For example, the pharmaceutical volatile bag of claim 1, wherein the other side is constituted by a sheet that cannot be wetted by the volatile pharmaceutical. A medicament volatilization container, comprising a medicament volatilization bag of claim 1 or 2 and a housing, the housing containing the medicament volatilization bag, and a portion corresponding to the inner bag body is provided with an inner bag through the outer bag body A pressing portion that imparts external force to the body. For example, the pharmaceutical volatilization container of claim 3, wherein the pharmaceutical volatilization bag is arranged with one of the outer bag bodies facing upward, and the housing is mounted on the member to be mounted.